Updated: Past failures shadow current hopes of testing drugs during an Ebola outbreak
Researchers set up a dozen clinical trials during the massive 2014 Ebola outbreak in West Africa. Only one was successful
Ebola virus
Read our COVID-19 research and news.
-
-
Has a new mutation in the Ebola virus made it deadlier?
Two new studies raise the possibility that an adaptation to humans speeded up transmission -
New reports highlight long-term risks from Ebola infection, limits of ZMapp
Scientists report long-lasting symptoms and evidence of virus's presence in semen 18 months after recovery -
Money donated to stockpile leading Ebola vaccine
GAVI cuts deal with Merck to make doses ready for future outbreaks -
WHO declares Ebola outbreak over
WHO declares Ebola outbreak over -
Plasma transfusions can't combat Ebola
Study finds no benefit of transferring antibodies from those who have survived -
New evidence that parts of Ebola virus hide in semen for months
Transmission of Ebola through sex may be more common than previously thought -
In wake of Ebola epidemic, Margaret Chan wants countries to put their money where their mouth is
WHO chief says her job has become "more and more political and more and more intense" -
-
Ebola vaccine works, offering 100% protection in African trial
Unusual clinical trial in Guinea offers promise for stopping epidemic -
Liberia’s Ebola epidemic ends
More than a month since last case -
-
Second Ebola vaccine trial may be too little, too late
Sierra Leone study may not have enough patients -
-
New Ebola drug trial starts in Sierra Leone
Study team hopes to have answers fast amid slowing epidemic -
